Unknown

Dataset Information

Clinical characteristics and outcome of patients with combined hepatocellular-cholangiocarcinoma-a European multicenter cohort.


ABSTRACT:

Background

There is no clear consensus on the optimal systemic treatment regimen in combined hepatocellular-cholangiocarcinoma (cHCC-CCA) patients. We describe clinical characteristics and outcome of cHCC-CCA patients, with a special focus on patients receiving palliative systemic therapy, including immune checkpoint inhibitors (ICIs).

Methods

In this European retrospective, multicenter study, patients with histologically proven cHCC-CCA treated at four institutions between April 2003 and June 2022 were included. In patients receiving palliative systemic therapy, outcome was compared between cytotoxic chemotherapy (CHT)- and non-cytotoxic CHT (nCHT)-treated patients.

Results

Of 101 patients, the majority were male (n = 70, 69%) with a mean age of 64.6 ± 10.6 years. On

SUBMITTER: Pomej K 

PROVIDER: S-EPMC10024130 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature